NOTE 9 – EMPLOYEE BENEFITS

Healthcare

Our healthcare benefit expense (net of employee contributions) for all plans was approximately $4.3 million and $3.5 million for the three months ended June 30, 2017 and 2016, respectively, and $8.3 million and $7.7 million for the six months ended June 30, 2017 and 2016, respectively. An accrual for estimated healthcare claims incurred but not reported (“IBNR”) is included within accrued compensation on the Condensed Consolidated Balance Sheets and was $1.8 million and $1.7 million as of June 30, 2017 and December 31, 2016, respectively.

Workers’ Compensation

Workers’ compensation expense totaled $2.6 million and $2.8 million for the three months ended June 30, 2017 and 2016, respectively, and $6.7 million and $5.8 million for the six months ended June 30, 2017 and 2016, respectively. Workers’ compensation known claims and IBNR reserves included on the Condensed Consolidated Balance Sheets were as follows (in thousands):


	June 30,		December 31,
	2017		2016
Included in other current liabilities	$	5,650	$	4,595
Included in other long-term liabilities		7,002		7,052

	$	12,652	$	11,647

We also had an insurance receivable for claims that exceeded the stop loss limit included on the Condensed Consolidated Balance Sheets. That receivable offsets an equal liability included within the reserve amounts noted above and was as follows (in thousands):


	June 30,		December 31,
	2017		2016
Included in other non-current assets	$	1,826	$	1,249

Share-Based Compensation

Directors

On June 1, 2017 and 2016, we granted approximately six thousand and nine thousand shares of our common stock, respectively, under our 2014 Omnibus Incentive Plan to non-employee members of our Board of Directors. Accordingly, for each of the three and six month periods ended June 30, 2017 and 2016, we recorded $0.3 million in compensation expense within administrative expenses on the Condensed Consolidated Statements of Operations and Comprehensive Income at the time of the grant. These shares vested on the grant date since there is no service period associated with these awards.

Employees

Common Stock Awards

During the six months ended June 30, 2017, we granted approximately 0.1 million shares of our common stock under our 2014 Omnibus Incentive Plan to our employees, which vest in three equal installments (rounded to the nearest whole share) on each of April 20, 2018, April 20, 2019 and April 20, 2020.

During the six months ended June 30, 2017, our employees surrendered approximately ten thousand shares of our common stock to satisfy tax withholding obligations arising in connection with the vesting of common stock awards issued under our 2014 Omnibus Incentive Plan. Share-based compensation expense associated with common stock awards was $0.7 million and $1.1 million for the three and six months ended June 30, 2017, respectively, and $0.3 million and $0.9 million for the three and six months ended June 30, 2016, respectively. We recognized excess tax benefits of $0.5 million and $0.6 million within the income tax provision in the Condensed Consolidated Statements of Operations and Comprehensive Income for the three and six months ended June 30, 2017, respectively, and $49 thousand and $0.3 million for the three and six months ended June 30, 2016.

Nonvested common stock awards for employees as of December 31, 2016 and changes during the six months ended June 30, 2017 were as follows:


	Common Stock Awards			Weighted Average Grant Date Fair Market Value Per Share
Nonvested common stock awards at December 31, 2016		161,174		$	26.36
Granted		101,241			52.00
Vested		(57,816	)		26.30
Forfeited		(1,157	)		31.13

Nonvested common stock awards at June 30, 2017		203,442		$	39.11

As of June 30, 2017, there was $7.0 million of unrecognized compensation expense related to these nonvested common stock awards. This expense is subject to future adjustments for forfeitures and is expected to be recognized on a straight-line basis over the remaining weighted-average period of 2.5 years. Shares forfeited are returned as treasury shares and available for future issuances.

As of June 30, 2017, approximately 2.6 million shares of common stock were available for issuance under the 2014 Omnibus Incentive Plan.

Performance-Based Stock

During the six months ended June 30, 2017, we established, and our Board of Directors approved, performance-based targets in connection with common stock awards to be issued to certain officers in 2018 contingent upon achievement of these targets. Share-based compensation expense associated with these performance-based awards was $0.3 million and $0.4 million for the three and six months ended June 30, 2017, respectively.

Nonvested performance-based stock awards for employees as of December 31, 2016 and changes during the six months ended June 30, 2017 were as follows:


	Performance- Based Stock Awards		Weighted Average Fair Market Value Per Share
Nonvested performance-based stock awards at December 31, 2016		—	$	—
Granted		77,254		41.00
Vested		—		—
Cancelled		—		—

Nonvested performance-based stock awards at June 30, 2017		77,254	$	41.00

As of June 30, 2017, there was $2.7 million of unrecognized compensation expense related to nonvested performance-based common stock awards. This expense is subject to future adjustments for forfeitures and is expected to be recognized over the remaining weighted-average period of 2.3 years using the graded-vesting method.

Performance-Based Restricted Stock Units

During the six months ended June 30, 2017, we established, and our Board of Directors approved, performance-based restricted stock units in connection with common stock awards to be issued to certain employees in 2018 contingent upon achievement of a performance target. Share-based compensation expense associated with these performance-based awards was $0.8 million for the three and six months ended June 30, 2017, respectively.

Nonvested performance-based stock units for employees as of December 31, 2016 and changes during the six months ended June 30, 2017 were as follows:


	Performance- Based Stock Units			Weighted Average Fair Market Value Per Share
Nonvested performance-based stock units at December 31, 2016		—		$	—
Granted		72,274			52.00
Vested		—			—
Cancelled		(471	)		52.00

Nonvested performance-based stock units at June 30, 2017		71,803		$	52.00

As of June 30, 2017, there was $3.0 million of unrecognized compensation expense related to nonvested performance-based common stock units. This expense is subject to future adjustments for forfeitures and is expected to be recognized on a straight-line basis over the remaining weighted-average period of 0.8 years.